Cresilon, Inc. is a pharmaceutical company based in New York that develops hemostatic products (products that stop bleeding). Its filings show it lobbied on medical research and manufacturing, specifically supporting research into hemostatic technology and the domestic production of hemostatic products. The company used The Conafay Group for lobbying and reported no lobbying spending in the disclosed filing.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
BRIAN TSE
The latest disclosures for this client.
THE CONAFAY GROUP, LLC
Q2THE CONAFAY GROUP, LLC
RRThe entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
THE CONAFAY GROUP, LLC
JULIE P. PAWELCZYK
THE CONAFAY GROUP, LLC
ms KRISTEN LAFAYETTE
THE CONAFAY GROUP, LLC